即时检测高敏心肌肌钙蛋白I测定性别特异性第99百分位参考上限的确定
研究采用AACC通用样本库中肝素化血浆,在Siemens POC Atellica VTLi hs-cTnI分析仪上测定693名表观健康者(男363、女330),排除使用糖化血红蛋白、NT-proBNP、eGFR及他汀者,用非参数法确定第99百分位参考上限。结果总体为23 ng/L、男性27 ng/L、女性18 ng/L,可测浓度≥LoD者总体83.7%、男性87.3%、女性79.7%,表明该POC分析仪符合高敏测定标准。
要点
- 该POC Atellica VTLi hs-cTnI分析仪在肝素化血浆中符合高敏测定标准。
- 性别特异性第99百分位参考上限:男性27 ng/L,女性18 ng/L。
- 可测浓度≥检测限的受试者比例总体为83.7%,男性87.3%,女性79.7%。
核心结论
- 新型POC Atellica VTLi hs-cTnI分析仪在肝素化血浆中符合高敏测定的定义。
- 性别特异性第99百分位参考上限为男性27 ng/L、女性18 ng/L,总体23 ng/L。
研究设计与样本
- 使用AACC通用样本库肝素化血浆,纳入表观健康受试者共693名(男性363、女性330)。
- 排除使用糖化血红蛋白、NT-proBNP、eGFR及他汀类药物的受试者。
- 在中心实验室的多台POC Atellica VTLi hs-cTnI分析仪上测定,第99百分位参考上限采用非参数法确定。
主要发现
- 男性和女性hs-cTnI浓度分布差异显著,排除前后均p<0.001。
- 第99百分位参考上限:总体23 ng/L(90%CI 20-32 ng/L),男性27 ng/L(CI 21-37 ng/L),女性18 ng/L(CI 9-78 ng/L)。
- 可测浓度≥检测限的受试者比例:总体83.7%,男性87.3%,女性79.7%。
- 检测限为1.24 ng/L,10%CV浓度为6.7 ng/L。
关键数值与推荐
- 高敏测定定义要求可测浓度≥检测限的受试者比例≥50%,且在性别特异性第99百分位处不精密度≤10%。
- 第99百分位参考上限:总体23 ng/L(90%CI 20-32 ng/L),男性27 ng/L(CI 21-37 ng/L),女性18 ng/L(CI 9-78 ng/L)。
临床怎么用
- 该POC hs-cTnI分析仪可采用性别特异性第99百分位参考上限用于临床。
- 使用肝素化血浆样本时,可依据男性27 ng/L、女性18 ng/L作为参考上限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: High sensitivity (hs) cardiac troponin (cTn) assays are defined per the IFCC Committee on Clinical Application of Cardiac Biomarker (C-CB) by the ability to measure ≥ 50% of concentrations greater than the limit of detection (LoD) with an impression of ≤10% at sex-specific 99th percentiles. Our study determined the sex-specific 99th percentile upper reference limits for males and females utilizing heparinized plasma from AACC universal sample bank for the Siemens point of care (POC) Atellica® VTLi hs-cTnI immunoassay. METHODS: Apparently healthy subjects, included overall 693, males 363, and females 330, following exclusionary surrogate biomarker use of hemoglobin A1c, NT-proBNP, and eGFR, along with statin medication. hs-cTnI was measured in a central laboratory, on multiple POC Atellica® VTLi immunoassay analyzers. The LoD was 1.24 ng/L and the 10%CV concentration was 6.7 ng/L. 99th percentile URLs were determined by the nonparametric (NP) method. RESULTS: Histograms of the hs-cTnI concentrations (ng/L) for males and females were used to visualize the distributions and concentrations in men and women and differed significantly (pre- and post-exclusion, both p <0.001). 99th percentile URLs were: overall 23 ng/L (90% CI 20-32 ng/L); male 27 ng/L (CI 21-37 ng/L); female 18 ng/L (CI 9-78 ng/L). The percentages of subjects having a measurable concentration ≥ the LoD were: overall 83.7%, male 87.3%, female 79.7%. CONCLUSIONS: Our findings show the novel POC Atellica® VTLi hs-cTnI assay meets the designation of a 'high-sensitivity' assay using heparinized plasma.
引用
- Apple FS, Schulz K, Schmidt CW, et al. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay. Clin Chem Lab Med. 2021. PMID: 34022125. doi:10.1515/cclm-2021-0262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。